Article
There may be just one predictor of urinary incontinence after pelvic organ prolapse repair-urinary incontinence.
Casdatifan is linked with promising safety, efficacy in clear cell RCC
Episode 3 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
Disitamab vedotin plus toripalimab shows safety, efficacy in MIBC
Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC
EV/pembrolizumab continues to show OS, PFS benefit vs chemotherapy in la/mUC
Additional NIAGARA data spotlight benefits of durvalumab plus chemo for MIBC